PubMed

New insight into CCN3 interactions--nuclear CCN3 : fact or fantasy?

Perbal B.

Cell Commun Signal. 2006 Aug 8;4:6.PMID: 16895594 [PubMed]Related articlesFree article

Nuclear addressing provides a clue for the transforming activity of amino-truncated CCN3 proteins.

Planque N, Long Li C, Saule S, Bleau AM, Perbal B.

J Cell Biochem. 2006 Sep 1;99(1):105-16.PMID: 16598765 [PubMed - indexed for MEDLINE]Related articles

CCN3 (NOV) is a negative regulator of CCN2 (CTGF) and a novel endogenous inhibitor of the fibrotic pathway in an in vitro model of renal disease.

Riser BL, Najmabadi F, Perbal B, Peterson DR, Rambow JA, Riser ML, Sukowski E, Yeger H, Riser SC.

Am J Pathol. 2009 May;174(5):1725-34. Epub 2009 Apr 9.PMID: 19359517 [PubMed - indexed for MEDLINE]Related articlesFree article

CCN3: Doctor Jekyll and Mister Hyde.

Perbal B.

J Cell Commun Signal. 2008 Jun;2(1-2):3-7. Epub 2008 Sep 12.PMID: 18784988 [PubMed - in process]Related articlesFree article

The CCN3 gene coding for an extracellular adhesion-related protein is transcriptionally activated by the p53 tumor suppressor.

Böhlig L, Metzger R, Rother K, Till H, Engeland K.

Cell Cycle. 2008 May 1;7(9):1254-61. Epub 2008 Feb 25.PMID: 18418052 [PubMed - indexed for MEDLINE]Related articles

CCN3--a key regulator of the hematopoietic compartment.

McCallum L, Irvine AE.

Blood Rev. 2009 Mar;23(2):79-85. Epub 2008 Aug 26. Review.PMID: 18752874 [PubMed - indexed for MEDLINE]Related articles

Potential cellular conformations of the CCN3(NOV) protein.

Kyurkchiev S, Yeger H, Bleau AM, Perbal B.

Cell Commun Signal. 2004 Sep 10;2(1):9.PMID: 15361251 [PubMed - as supplied by publisher]Related articlesFree article

Antiproliferative activity of CCN3: involvement of the C-terminal module and post-translational regulation.

Bleau AM, Planque N, Lazar N, Zambelli D, Ori A, Quan T, Fisher G, Scotlandi K, Perbal B.

J Cell Biochem. 2007 Aug 15;101(6):1475-91.PMID: 17340618 [PubMed - indexed for MEDLINE]Related articles

CCN3/nephroblastoma overexpressed matricellular protein regulates integrin expression, adhesion, and dissemination in melanoma.

Vallacchi V, Daniotti M, Ratti F, Di Stasi D, Deho P, De Filippo A, Tragni G, Balsari A, Carbone A, Rivoltini L, Parmiani G, Lazar N, Perbal B, Rodolfo M.

Cancer Res. 2008 Feb 1;68(3):715-23. Erratum in: Cancer Res. 2008 Mar 15;68(6):2051. PMID: 18245471 [PubMed - indexed for MEDLINE]Related articlesFree article

Expression of CCN3 protein in human Wilms' tumors: immunohistochemical detection of CCN3 variants using domain-specific antibodies.

Subramaniam MM, Lazar N, Navarro S, Perbal B, Llombart-Bosch A.

Virchows Arch. 2008 Jan;452(1):33-9. Epub 2007 Dec 8.PMID: 18066593 [PubMed - indexed for MEDLINE]Related articles

Domain-specific CCN3 antibodies as unique tools for structural and functional studies.

Lazar N, Manara C, Navarro S, Bleau AM, Llombart-Bosch A, Scotlandi K, Planque N, Perbal B.

J Cell Commun Signal. 2007 Sep;1(2):91-102. Epub 2007 Sep 8.PMID: 18481200 [PubMed - as supplied by publisher]Related articlesFree article

Matricellular protein CCN3 (NOV) regulates actin cytoskeleton reorganization.

Sin WC, Tse M, Planque N, Perbal B, Lampe PD, Naus CC.

J Biol Chem. 2009 Oct 23;284(43):29935-44. Epub 2009 Aug 25.PMID: 19706598 [PubMed - indexed for MEDLINE]Related articles

CCN3: a key growth regulator in Chronic Myeloid Leukaemia.

McCallum L, Lu W, Price S, Lazar N, Perbal B, Irvine AE.

J Cell Commun Signal. 2009 Jun;3(2):115-24. Epub 2009 Jul 22.PMID: 19623482 [PubMed - in process]Related articlesFree article

Nephroblastoma overexpressed/cysteine-rich protein 61/connective tissue growth factor/nephroblastoma overexpressed gene-3 (NOV/CCN3), a selective adrenocortical cell proapoptotic factor, is down-regulated in childhood adrenocortical tumors.

Doghman M, Arhatte M, Thibout H, Rodrigues G, De Moura J, Grosso S, West AN, Laurent M, Mas JC, Bongain A, Zambetti GP, Figueiredo BC, Auberger P, Martinerie C, Lalli E.

J Clin Endocrinol Metab. 2007 Aug;92(8):3253-60. Epub 2007 Jun 12.PMID: 17566092 [PubMed - indexed for MEDLINE]Related articlesFree article

Downregulation of CCN3 expression as a potential mechanism for melanoma progression.

Fukunaga-Kalabis M, Martinez G, Telson SM, Liu ZJ, Balint K, Juhasz I, Elder DE, Perbal B, Herlyn M.

Oncogene. 2008 Apr 17;27(18):2552-60. Epub 2007 Oct 29.PMID: 17968313 [PubMed - indexed for MEDLINE]Related articles

Inhibitory effect of CT domain of CCN3/NOV on proliferation and differentiation of osteogenic mesenchymal stem cells, Kusa-A1.

Katsuki Y, Sakamoto K, Minamizato T, Makino H, Umezawa A, Ikeda MA, Perbal B, Amagasa T, Yamaguchi A, Katsube K.

Biochem Biophys Res Commun. 2008 Apr 11;368(3):808-14. Epub 2008 Feb 12.PMID: 18275847 [PubMed - indexed for MEDLINE]Related articles

Prognostic value of CCN3 in osteosarcoma.

Perbal B, Zuntini M, Zambelli D, Serra M, Sciandra M, Cantiani L, Lucarelli E, Picci P, Scotlandi K.

Clin Cancer Res. 2008 Feb 1;14(3):701-9.PMID: 18245529 [PubMed - indexed for MEDLINE]Related articlesFree article

CCN3 is a novel endogenous PDGF-regulated inhibitor of glomerular cell proliferation.

van Roeyen CR, Eitner F, Scholl T, Boor P, Kunter U, Planque N, Gröne HJ, Bleau AM, Perbal B, Ostendorf T, Floege J.

Kidney Int. 2008 Jan;73(1):86-94. Epub 2007 Oct 10.PMID: 17914348 [PubMed - indexed for MEDLINE]Related articles

Dose-dependent differential upregulation of CCN1/Cyr61 and CCN3/NOV by the gap junction protein Connexin43 in glioma cells.

Sin WC, Bechberger JF, Rushlow WJ, Naus CC.

J Cell Biochem. 2008 Apr 15;103(6):1772-82.PMID: 18004727 [PubMed - indexed for MEDLINE]Related articles

CCN3/NOV inhibits BMP-2-induced osteoblast differentiation by interacting with BMP and Notch signaling pathways.

Minamizato T, Sakamoto K, Liu T, Kokubo H, Katsube K, Perbal B, Nakamura S, Yamaguchi A.

Biochem Biophys Res Commun. 2007 Mar 9;354(2):567-73. Epub 2007 Jan 16.PMID: 17250806 [PubMed - indexed for MEDLINE]Related articles